Sorafenib in Treating Patients With Advanced Malignant Solid Tumors

NCT00810394 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Sorafenib

Sponsor

University of California, Davis

Collaborators

[object Object]